Literature DB >> 8111250

Inhibition of enteropathogenic Escherichia coli (EPEC) adhesion to HeLa cells by human colostrum: detection of specific sIgA related to EPEC outer-membrane proteins.

L M Camara1, S B Carbonare, M L Silva, M M Carneiro-Sampaio.   

Abstract

Human colostrum and a high molecular weight colostrum fraction (HMWF; > 14,000 D) prevented the adhesion of localized adherent (LA+) O111:H-enteropathogenic Escherichia coli (EPEC) to HeLa cells. This effect was abolished after absorption with an O111:H-LA + EPEC strain, but absorption with a LA- strain of same serotype had no effect on the process. A low molecular weight fraction (< 14,000 D), absorbed or not with LA+ or LA- bacterial strains, did not inhibit the adherence of E. coli to HeLa cells. IgA-depleted colostrum had no inhibitory effect on bacterial adhesion, demonstrating the critical role of this protein in the phenomenon. Heat inactivation of whole colostrum did not significantly modify the inhibition adherence levels. Immunoblots of O111:H-LA+ strain outer-membrane complex reacted with colostrum and HMWF showing that IgA antibodies were predominantly reactive with a 94-kD protein. These data confirm and extend observations about colostrum sIgA participation in adhesion inhibition of EPEC to HeLa cells and its response to a 94-kD outer-membrane protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111250     DOI: 10.1159/000236645

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies.

Authors:  A Parissi-Crivelli; J M Parissi-Crivelli; J A Girón
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 2.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium.

Authors:  P C D Ferreira; J B da Silva; R M F Piazza; L Eckmann; P L Ho; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

4.  Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model.

Authors:  Carla Calderon Toledo; Ida Arvidsson; Diana Karpman
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

5.  Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin A antibodies isolated from human breast milk.

Authors:  H A Manjarrez-Hernandez; S Gavilanes-Parra; E Chavez-Berrocal; A Navarro-Ocaña; A Cravioto
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Identification of immunodominant regions within the C-terminal cell binding domain of intimin alpha and intimin beta from enteropathogenic Escherichia coli.

Authors:  J Adu-Bobie; L R Trabulsi; M M Carneiro-Sampaio; G Dougan; G Frankel
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.

Authors:  Rogeria Keller; Tamara D Hilton; Hernam Rios; Edgar C Boedeker; James B Kaper
Journal:  Microb Pathog       Date:  2009-10-28       Impact factor: 3.738

9.  Transfer of maternal immunity to newborns of diabetic mothers.

Authors:  Eduardo Luzía França; Iracema de Mattos Paranhos Calderon; Elisa Lima Vieira; Glilciane Morceli; Adenilda Cristina Honorio-França
Journal:  Clin Dev Immunol       Date:  2012-09-09

10.  Human milk secretory antibodies against attaching and effacing Escherichia coli antigens.

Authors:  Marita Noguera-Obenza; Theresa J Ochoa; Henry F Gomez; M Lourdes Guerrero; Irene Herrera-Insua; Ardythe L Morrow; Guillermo Ruiz-Palacios; Larry K Pickering; Carlos A Guzman; Thomas G Cleary
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.